Description

CICLOHALE INHALER 80MCG 120MD

Indications

Ciclohale Inhaler 80mcg 120md is primarily indicated for the management of asthma and chronic obstructive pulmonary disease (COPD). It is used as a maintenance treatment to help control symptoms and improve lung function in patients with these respiratory conditions. The inhaler delivers a precise dose of the active ingredient, ensuring effective bronchodilation and relief from symptoms such as wheezing, shortness of breath, and chest tightness.

Mechanism of Action

The active ingredient in Ciclohale Inhaler is a long-acting beta-2 adrenergic agonist (LABA). It works by stimulating beta-2 adrenergic receptors in the smooth muscle of the airways, leading to relaxation of these muscles. This bronchodilation effect helps to open the airways, making it easier for patients to breathe. The onset of action typically occurs within 15 minutes, and the effects can last for up to 12 hours, providing extended relief from respiratory symptoms.

Pharmacological Properties

Ciclohale Inhaler contains a formulation designed for inhalation, allowing for direct delivery of the medication to the lungs. This method of administration enhances the therapeutic effect while minimizing systemic side effects. The pharmacokinetics of the active ingredient indicate that it has a high affinity for beta-2 receptors, which contributes to its prolonged action. The inhaler is designed to deliver a consistent dose of 80 mcg per actuation, with a total of 120 doses available in each device.

Contraindications

Ciclohale Inhaler is contraindicated in patients with a known hypersensitivity to the active ingredient or any of the excipients in the formulation. Additionally, it should not be used as a rescue medication for acute asthma attacks or severe COPD exacerbations. Patients with certain cardiovascular conditions, such as severe hypertension or arrhythmias, should also avoid using this inhaler unless specifically directed by a healthcare provider.

Side Effects

Common side effects associated with the use of Ciclohale Inhaler may include tremors, headache, palpitations, and muscle cramps. Some patients may experience throat irritation or a dry mouth after inhalation. While serious side effects are rare, they can occur and may include paradoxical bronchospasm, elevated blood pressure, and tachycardia. Patients should be advised to seek medical attention if they experience any severe or persistent side effects.

Dosage and Administration

The recommended dosage for adults and children over the age of 12 is one inhalation (80 mcg) taken twice daily, ideally at the same times each day to maintain consistent therapeutic levels. It is important for patients to use the inhaler correctly to ensure optimal drug delivery. Patients should be instructed on the proper inhalation technique, including shaking the inhaler before use and inhaling deeply while activating the device. Regular follow-up with a healthcare provider is essential to assess the effectiveness of the treatment and make any necessary adjustments.

Interactions

Ciclohale Inhaler may interact with other medications, particularly those that affect the cardiovascular system. Caution should be exercised when used in conjunction with other sympathomimetic agents, as this may increase the risk of cardiovascular side effects. Additionally, certain medications used for the treatment of hypertension or arrhythmias may have additive effects when combined with Ciclohale. Patients should inform their healthcare provider of all medications they are taking to avoid potential interactions.

Precautions

Patients using Ciclohale Inhaler should be monitored for any changes in their respiratory status, particularly during initiation of therapy or dosage adjustments. It is crucial to ensure that patients understand the difference between maintenance therapy and rescue medications, as Ciclohale is not intended for immediate relief of acute symptoms. Special caution is advised in patients with a history of seizures, hyperthyroidism, or diabetes, as the medication may exacerbate these conditions. Pregnant or breastfeeding women should consult their healthcare provider before using this inhaler.

Clinical Studies

Clinical studies have demonstrated the efficacy of Ciclohale Inhaler in improving lung function and reducing the frequency of asthma and COPD exacerbations. In a randomized controlled trial, patients using the inhaler showed significant improvements in forced expiratory volume (FEV1) and a reduction in the use of rescue inhalers compared to those receiving a placebo. Long-term studies have also indicated that the use of Ciclohale can lead to improved quality of life and reduced symptom burden in patients with chronic respiratory conditions.

Conclusion

Ciclohale Inhaler 80mcg 120md is a valuable therapeutic option for patients suffering from asthma and COPD. Its long-acting formulation provides sustained bronchodilation, helping to manage symptoms effectively. However, it is essential for patients to use the inhaler as directed and to maintain regular communication with their healthcare providers to optimize treatment outcomes. Understanding the medication’s indications, side effects, and proper usage is crucial for ensuring safe and effective management of respiratory conditions.